In addition, while complement classical pathway genes were enriched in low-risk patients, GO and KEGG analysis implicated that signaling pathways such as inflammatory response, response to interferon-gamma, and positive regulation of immune response were negatively correlated with risk score, implicating that the increased levels of immune and inflammatory response might facilitate anti-tumor activities and result in better survival in low-risk patients. Here, IFNG is linked to neoplasm.